Emerging Next-Generation Target for Cancer Immunotherapy Research: The Orphan Nuclear Receptor NR2F6
Additional therapeutic targets suitable for boosting anti-tumor effector responses have been found inside effector CD4<sup>+</sup> and CD8<sup>+</sup> T cells. It is likely that future treatment options will combine surface receptor and intracellular protein targets. Utilizin...
Main Authors: | Victoria Klepsch, Kerstin Siegmund, Gottfried Baier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/11/2600 |
Similar Items
-
Targeting the orphan nuclear receptor NR2F6 in T cells primes tumors for immune checkpoint therapy
by: Victoria Klepsch, et al.
Published: (2020-01-01) -
New Insights into the Diverse Functions of the NR2F Nuclear Orphan Receptor Family
by: Tajana Sajinovic, et al.
Published: (2023-01-01) -
CD3<sup>+</sup>, CD8<sup>+</sup>, CD4<sup>+</sup> and FOXP3<sup>+</sup> T Cells in the Immune Microenvironment of Small Bowel Neuroendocrine Tumors
by: Niko Hiltunen, et al.
Published: (2021-06-01) -
CELL-MEDIATED IMMUNITY IN PATIENTS WITH POSTTRAUMATIC LONG BONE OSTEOMYELITIS IN THE COURSE OF MANAGEMENT WITH THE ILIZAROV METHOD
by: M. V. Chepeleva, et al.
Published: (2019-02-01) -
<i>Nr1d1</i> Mediated Cell Senescence in Mouse Heart-Derived Sca-1<sup>+</sup>CD31<sup>−</sup> Cells
by: Shiming Pu, et al.
Published: (2022-10-01)